Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001851642 | SCV002179972 | uncertain significance | not provided | 2021-08-19 | criteria provided, single submitter | clinical testing | This sequence change replaces asparagine with tyrosine at codon 208 of the EIF2B1 protein (p.Asn208Tyr). The asparagine residue is highly conserved and there is a large physicochemical difference between asparagine and tyrosine. This variant is present in population databases (rs113994007, ExAC 0.009%). This missense change has been observed in individual(s) with leukoencephalopathy with vanishing white matter (PMID: 11835386). ClinVar contains an entry for this variant (Variation ID: 4124). Algorithms developed to predict the effect of missense changes on protein structure and function (SIFT, PolyPhen-2, Align-GVGD) all suggest that this variant is likely to be disruptive. Experimental studies have shown that this missense change affects EIF2B1 function (PMID: 26285592). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. |
OMIM | RCV000004340 | SCV000024511 | pathogenic | Vanishing white matter disease | 2015-08-19 | no assertion criteria provided | literature only |